Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 9, 2018 - The FDA approved an update to the Warning and Precautions section of the Rexulti (brexpiprazole) drug label regarding pathological gambling and other compulsive behaviors.
Return to publications